Related Experiment Videos
Cyclooxygenase isozymes and their gene structures and expression
Tadashi Tanabe1, Norimitsu Tohnai
1Department of Pharmacology, National Cardiovascular Center Research Institute, Suita, Osaka, Japan. tanabe@jsc.ri.ncvc.go.jp
Prostaglandins & Other Lipid Mediators
|November 16, 2002
Summary
Cyclooxygenase-1 (COX-1) is a housekeeping enzyme, while cyclooxygenase-2 (COX-2) is inducible. COX-2 expression is regulated by various factors and signaling pathways, including mitogen-activated protein kinase (MAPK).
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Cyclooxygenase (COX) is crucial for prostaglandin biosynthesis.
- Two isoforms, COX-1 and COX-2, exhibit distinct expression patterns and regulatory mechanisms.
- COX-1 is constitutively expressed, functioning as a housekeeping gene, while COX-2 is inducible.
Purpose of the Study:
- To elucidate the molecular mechanisms governing the expression of COX-1 and COX-2 isoforms.
- To differentiate the regulatory elements and signaling pathways involved in COX-2 gene expression.
Main Methods:
- Comparative analysis of COX-1 and COX-2 gene structures and promoter regions.
- Identification of cis-regulatory elements in the 5'-flanking region of COX-2.
- Investigation of signaling pathways, including mitogen-activated protein kinase (MAPK), in COX-2 regulation.
Main Results:
- COX-1 promoter lacks TATA/CAAT boxes and is GC-rich, characteristic of housekeeping genes.
- COX-2 expression is induced by cytokines and mitogens but suppressed by dexamethasone and PGJ2.
- Multiple cis-elements (CRE, NF-kappaB, NF-IL6, E-box) in the COX-2 5'-flanking region regulate transcription.
- MAPK signaling pathways are critical for both transcriptional and post-transcriptional regulation of COX-2.
Conclusions:
- COX-1 and COX-2 possess distinct regulatory strategies reflecting their different biological roles.
- COX-2 gene expression is tightly controlled by a complex interplay of cis-elements and signaling pathways, notably MAPK.
- Understanding these regulatory mechanisms is vital for targeted therapeutic interventions involving prostaglandin synthesis.